$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Possible side effects of EIKANCE 0.01% Atropine Sulfate Eye Drops and possible harm caused by long-term use
2026-02-01 22:25:32
Check Details
Analysis of reimbursement ratio, policy changes and drug purchase precautions after Pretomanid is included in medical insurance
2026-02-01 22:25:32
Check Details
How effective is voclosporin treatment? Comprehensive analysis of clinical data and real patient feedback
2026-02-01 22:25:32
Check Details
What is ponatinib? Full explanation of pharmacological mechanisms, indications and clinical use
2026-02-01 22:25:32
Check Details
Summary and analysis of the efficacy and clinical application of safinamide mesylate tablets (Siddaco) in Parkinson's disease
2026-02-01 22:25:32
Check Details
Whether Tarlatamab-Imdelltra is available in China and analysis of drug purchase channels in various places
2026-02-01 22:25:32
Check Details
Analysis and summary of telisotuzumab-EMRELIS cure rate and patient efficacy in clinical application
2026-02-01 22:25:32
Check Details
Tovorafenib resistance time and influencing factors, clinical countermeasures and patient experience summary
2026-02-01 22:25:32
Check Details
Summary of vorasidenib-VORANIGO clinical trial data and efficacy and resistance in different indications
2026-02-01 22:25:32
Check Details
Detailed description of Zongatinib (Zongatinib) indications, main disease types and clinical application guidelines
2026-02-01 22:25:32
Check Details
A complete explanation of the applicable populations and clinical applications of vosoritide
2026-02-01 22:25:32
Check Details
The leukemia targeted drug Gilteritinib has been launched in China, and its clinical efficacy and medication methods are explained in detail
2026-02-01 22:25:32
Check Details
1
2
...
2426
2427
2428
2429
2430
2431
2432
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
ROS and Cancer: The Potential of Natural Antioxidants
2
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
3
Breaking the Bottleneck: KOSELUGO® (Selumetinib) Reshapes the Treatment Landscape for Neurofibromatosis Type 1 (NF1)
4
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
5
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
6
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
7
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
8
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
9
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
10
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
11
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
12
Adagrasib Medication Management Guide for Special Populations